TGFBR2 and neoplasm: To mimic this population of patients and understand the responsiveness of TGFβR2‐mutant tumor cells to TGFβ, we generated two TGFβR2‐deficient pancreatic cancer cell lines Tgfbr2mut1 and Tgfbr2mut2.